Previous 10 | Next 10 |
2023-05-15 10:19:06 ET Fulcrum Therapeutics, Inc. (FULC) Q1 2023 Earnings Conference Call May 15, 2023 08:00 A.M. ET Company Participants Chris Calabrese - LifeSci Advisors, LLC Robert J. Gould - President and CEO Iain Fraser - Interim Chief Medical Officer ...
2023-05-15 07:33:47 ET A clinical-stage biopharmaceutical company, Fulcrum Therapeutics ( NASDAQ: FULC ) appoints Alex C. Sapir as CEO and president, effective July 1, 2023. Upon assuming his new role, Mr. Sapir will also join Fulcrum’s board of ...
2023-05-15 07:12:02 ET Fulcrum Therapeutics press release ( NASDAQ: FULC ): Q1 GAAP EPS of -$0.41 beats by $0.05 . Revenue of $0.3M (-88.5% Y/Y) misses by $0.68M . “With today’s announcement of Alex as our next CEO and President, Fulcrum has ended...
― Appointed Alex C. Sapir CEO & President, effective July 1st, 2023 ― ― On track to complete enrollment in Phase 3 REACH trial of losmapimod in facioscapulohumeral muscular dystrophy (FSHD) during 2H’23 ― ― Active discuss...
— Industry veteran brings more than 20 years of experience; will assume role effective July 1 st — — During transition period Mr. Sapir will serve as special advisor to the interim CEO and president — CAMBRIDGE, Mass., May 15, 2023 (GLOBE ...
CAMBRIDGE, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its first quart...
2023-04-25 14:05:50 ET Summary Today, we circle back on development firm Fulcrum Therapeutics whose shares have been hit by a litany of bad news in 2023. However, the stock now sells for less than net cash, has one late stage candidate and could resolve a key clinical hold in the ...
2023-04-11 17:33:17 ET Gainers: PDF Solutions ( PDFS ) +4% . Phathom Pharmaceuticals ( PHAT ) +3% . Frontier Communications Parent ( FYBR ) +3% . InflaRx ( IFRX ) +2% . PENN Entertainment ( PENN ) +2% . Losers: Melco Reso...
2023-04-06 17:02:48 ET Gainers: Ramaco Resources ( METC ) +5% . Aemetis ( AMTX ) +5% . El Pollo Loco Holdings ( LOCO ) +5% . Independent Bank Corporation ( IBCP ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: Nurix Th...
2023-04-05 08:21:23 ET Biopharmaceutical company Fulcrum Therapeutics ( NASDAQ: FULC ) said on Wednesday that Esther Rajavelu has resigned as CFO and treasurer, effective April 21. Rajavelu is set to serve in a consulting role after the effective date. Source: ...
News, Short Squeeze, Breakout and More Instantly...
Fulcrum Therapeutics Inc. Company Name:
FULC Stock Symbol:
NYSE Market:
Fulcrum Therapeutics Inc. Website:
CAMBRIDGE, Mass., June 12, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today a...
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today a...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...